CASE CONTROL STUDY.pptx

1,188 views 41 slides Jul 18, 2022
Slide 1
Slide 1 of 41
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41

About This Presentation

case-control study design basics


Slide Content

CASE CONTROL STUDY Dr. Chirag R Sonkusare Dr. Komal Shelke 18-07-2022 1

EPIDEMIOLOGY: “The study of the occurrence and distribution of health-related events, states, and processes in specified populations including the study of determinants influencing such processes and the application of this knowledge to control relevant health problems”. 18-07-2022 2

18-07-2022 3

HISTORY The first modern case control study was Janet Lane Claypons study of breast cancer in 1926. It grew in popularity in 1950s after the publication of four case control studies that established in link between smoking and lung cancer. 18-07-2022 4

Definition: A method of sampling a population in which: Cases (Disease) are identified and enrolled Controls (Non disease) Cases and controls must be comparable with respect to known “Confounding factors” such as Age, sex, occupation, social status, etc. Unit is the Individual. 18-07-2022 5

Case control studies are Observational, Analytical studies & Retrospective studies Three distinct features of case control study : 1.Exposure and outcome have occurred before the start of the study 2.Proceed backwords from effect to cause 3.Uses controls or comparison group. OUTCOME/ DISEASE EXPOSURE/ CAUSE 18-07-2022 6

DESIGN OF CASE CONTROL STUDY 18-07-2022 7

When is it desirable to conduct a case control study ? When exposure data are expensive or difficult to obtain - Ex. Pesticide study When disease has long induction and latent period - Ex. Cancer, cardiovascular diseases When the disease is rare - Ex. Studying risk factors for birth defects 18-07-2022 8

When little is known about the disease - Ex. Early studies of AIDS When underlying population is dynamic - Ex. Studying breast cancer 18-07-2022 9

Framework of case control study Suspected or risk factors Cases (disease present) Control (disease absent) Present a b Absent c d a + c b + d 18-07-2022 10

Basic steps Four basic steps in conducting a case control study: 1. Selection of cases and controls 2. Matching 3. Measurement of exposure 4. Analysis and Interpretation 18-07-2022 11

1. Selection Of Cases And Controls A. Definition of case: Diagnostic Criteria- -Diagnostic criteria of disease and stage of the disease (e.g., breast cancer stage I must be included in the study must be specified. -Once the diagnostic criteria are established, they should not be changed till the study is over. 18-07-2022 12

Eligibility Criteria -Only newly diagnosed (incident) cases within a specified period of time are eligible -Not old cases or cases in advanced stages of disease(prevalent cases) 18-07-2022 13

B.Sources of cases: a) Hospitals: Cases may be drawn from a single hospital or a network of hospitals ,admitted during a specified period of time. The entire case series or random sample of it is selected. b)General population: All cases of the study disease occurring within a defined geographic area, during a specified period of time are ascertained, often through a survey, a disease registry or hospital network The cases should be representative of all cases in community. 18-07-2022 14

SELECTION OF CONTROLS : Must be similar to the cases but free from the disease. As a rule, comparison group identified before a study is done Difficulties may arise if the disease under investigation occurs in subclinical forms 18-07-2022 15

SOURCES OF CONTROLS 1.HOSPITAL CONTROLS: Controls may be selected from same hospital as cases, but with different illneses other than study disease. Hospital controls are often a source of “selection bias”. 2. RELATIVES: Sibling controls are unsuitable where genetic conditions are under study. 18-07-2022 16

3. NEIGHBOURHOOD CONTROLS: Controls may be drawn from persons living in same locality as cases, persons working in the same factory or children attending the same school. 4. GENERAL POPULATION: Population controls can be obtained from defined geographic areas, by taking a random sample of individuals. 18-07-2022 17

Since both the cases and the hospital controls are selected from the defined population, any factors that affected admission of cases to a certain hospital would also affect the admission of hospital TOTAL POPULATION CASES DEFINED POPULATION TOTAL POPULATION Defined population Cases Controls 18-07-2022 18

2. MATCHING Matching is defined as, the process by which we select controls in such a way that they are similar to cases with regard to certain pertinent selected variables( eg. Age) which are known to influence the outcome of disease and which, if not adequately matched for comparability, could distort or confound the results. 18-07-2022 19

Examples to explain confounding. In the study of the role of alcohol in the aetiology of oesophageal cancer, smoking is a confounding factor because -It is associated with alcohol consumption -It is an independent risk factor for oesophageal cancer Matching protects against an unexpected strong association between the matching factor(eg. smoking) and the disease (oesophageal cancer) 18-07-2022 20

3. MEASUREMENT OF EXPOSURE: Information about exposure should be obtained in precisely the same manner both for cases and controls. Obtained by interviews, by questionnaires or by studying past records of cases such as hospital records, employment records, etc. 18-07-2022 21

4. ANALYSIS: The final step, to find out a) Exposure rates among cases and controls to suspected factor b) Estimation of disease risk associated with exposure(Odds ratio) 18-07-2022 22

a) Exposure rates: Cases ( with lung cancer) Controls (without lung cancer) Total Smokers (less than 5 cigarettes a day) 33 (a) 55 (b) 88 (a+b) Non-smokers 2 (c) 27 (d) 29 (c+d) Total 35 (a+c) 82 (b+d) n = a+b+c+d 18-07-2022 23

b) Estimation of risk The estimation of disease risk associated with exposure is obtained by an index known as “Relative Risk”or “Risk ratio” 18-07-2022 24

ODDS RATIO (CROSS-PRODUCT) Which is a measure of the strength of the association between risk factor and outcome. The derivation of odds ratio is based on three assumptions: -The disease being investigated must be relatively rare -The cases must be representative of those with disease. -The controls must be representative of those without the disease 18-07-2022 25

Bias in case control studies: Bias is any systematic error in determination of association between exposure and disease. 1. Bias due to confounding : This can be removed by matching 2. Memory or recall bias : When cases and controls are asked questions about their past history, it may be more likely for the cases to recall the existence of certain events or factors, than the controls 18-07-2022 26

3.Selection bias: The selection bias can be best controlled by its prevention. 4.Berkesonian bias: The bias arises because of the different rates of admission to hospitals for people with different diseases.(i.e hospital cases and controls) 18-07-2022 27

5. Interviewers bias: -Bias may also occue when the interviewer knows the hypothesis and also knows who the cases are. -The prior information may lead him to question the cases more thoroughly than controls. 18-07-2022 28

Comparison of Case Control study and Cohort study Features Case Control study Cohort study Type of design Observational, Analytical Observational, Analytical Temporality Retrospective (backward in time) Prospective (forward in time) Direction of reasoning From outcome to exposure From exposure to outcome Occurrence of outcome output already occurred Outcome not occurred (ex: retrospective cohort) Strength of association Odds ratio Risk ratio Temporal association Not proven proven Recall bias/ Survivorship bias Potential problem Not a major issue Lost to follow up bias Not a major issue Potential problem Time Results available quickly Takes a long time No. of subjects Small sample size Large sample size Logistics efforts Less costly, req. less logistics Expensive, lot of efforts 18-07-2022 29

Design of case control study Cases (with disease) Control (without disease) Exposed a b Non exposed c d Total a+c b+d Proportions who were exposed a/ a+c b/ b+d 18-07-2022 30

We find that of the 200 CHD cases, 112 were smokers and 88 were nonsmokers. Of the 400 controls, 176 were smokers and 224 were nonsmokers. CHD Cases Controls Exposed (cigarette smoker) 112 176 Non exposed (do not smoke cigarette) 88 224 Total 200 400 % Smoking cigarettes 56 % 44 % 18-07-2022 31

Distribution of 1,357 Male Lung Cancer Patients and a Male Control Group According to Average Number of Cigarettes Smoked Daily Over the 10 Years Preceding Onset of the Current Illness Average Daily Cigarettes Lung Cancer Patients Control Group 7 61 1-4 55 129 5-14 489 570 15-24 475 431 25-49 293 154 50+ 38 12 Total 1357 1357 From doll and hill. A study of the aetiology of carcinoma of the lung BMJ 1952:1271-1286 18-07-2022 32

Examples of Case-Control Studies 18-07-2022 33

Selection of cases and controls Selection of cases:- The investigator should define the cases as specifically as possible. Sometimes, definition of a disease may be based on multiple criteria; thus, all these points should be explicitly stated in case definition. Selection of controls:- an important aspect of selecting a control is that they should be from the same ‘study base’ as that of the cases. Thus, the pool of population from which the cases and controls will be enrolled should be same. 18-07-2022 34

Smoking and lung cancer study In their landmark study, Doll and Hill (1950) evaluated the association between smoking and lung cancer. They included 709 patients of lung carcinoma (defined as cases). They also included 709 controls from general medical and surgical patients. The selected controls were similar to the cases with respect to age and sex. Thus, they included 649 males and 60 females in cases as well as controls. They found that only 0.3% of males were non-smokers among cases . However, the proportion of nonsmokers among controls was 4.2%; the different was statistically significant ( P = 0.00000064). Similarly , they found that about 31.7% of the female were non-smokers in cases compared with 53.3% in controls ; this difference was also statistically significant (0.01< p <0.02). 18-07-2022 35

Melanoma and training ( lazovic et al. 2010) The authors conducted a case-control study to study the association between melanoma and tanning. The 1167 cases - individuals with invasive cutaneous melanoma – were selected from Minnesota Cancer Surveillance System. The 1101 controls were selected randomly from Minnesota State Driver's License list; they were matched for age (+/- 5 years) and sex. The data were collected by self administered questionnaires and telephone interviews. The investigators assessed the use of tanning devices (using photographs), number of years, and frequency of use of these devices. They also collected information on other variables (such as sun exposure; presence of freckles and moles; and colour of skin, hair, among other exposures. They found that melanoma was higher in individuals who used UVB enhances and primarily UVA-emitting devices. The risk of melanoma also increased with increase in years of use, hours of use, and sessions. 18-07-2022 36

Risk factors for erysipelas ( Pitche et al 2015) Pitché et al (2015) conducted a case-control study to assess the factors associated with leg erysipelas in sub-Saharan Africa. This was a multi- centre study; the cases and controls were recruited from eight countries in sub-Saharan Africa. They recruited cases of acute leg cellulitis in these eight countries. They recruited two controls for each case; these were matched for age (+/- 5 years) and sex. Thus, the final study has 364 cases and 728 controls. They found that leg erysipelas was associated with obesity, lympoedema , neglected traumatic wound, toe-web intertrigo, and voluntary cosmetic depigmentation. 18-07-2022 37

Strengths of a Case-Control Study Case-Control studies can usually be conducted relatively faster and are inexpensive – particularly when compared with cohort studies (prospective) It is useful to study rare outcomes and outcomes with long latent periods. For example, if we wish to study the factors associated with melanoma in India, it will be useful to conduct a case-control study. We will recruit cases of melanoma as cases in one study site or multiple study sites. If we were to conduct a cohort study for this research question, we may to have follow individuals (with the exposure under study) for many years before the occurrence of the outcome 18-07-2022 38

It is also useful to study multiple exposures in the same outcome. For example, in the metabolic syndrome and psoriasis study, we can study other factors such as Vitamin D levels or genetic markers Case-control studies are useful to study the association of risk factors and outcomes in outbreak investigations. For instance, Freeman and colleagues (2015) in a study published in 2015 conducted a case-control study to evaluate the role of proton pump inhibitors in an outbreak of non-typhoidal salmonellosis. 18-07-2022 39

Limitations of a Case-control Study The design, in general, is not useful to study rare exposures . It may be prudent to conduct a cohort study for rare exposures We are not able to estimate the incidence or prevalence in a case-control study Why can’t we comment on the incidence or prevalence of the disease? Since the investigator chooses the number of cases and controls, the proportion of cases may not be representative of the proportion in the population. For instance if we choose 50 cases of psoriasis and 50 controls, the prevalence of proportion of psoriasis cases in our study will be 50%. This is not true prevalence. If we had chosen 50 cases of psoriasis and 100 controls, then the proportion of the cases will be 33%. 18-07-2022 40

The design is not useful to study multiple outcomes. Since the cases are selected based on the outcome, we can only study the association between exposures and that particular outcome Sometimes the temporality of the exposure and outcome may not be clearly established in case-control studies The case-control studies are also prone to certain biases In general, individuals may not be able to recall all exposures accurately. 18-07-2022 41